DEA Rescheduling and Form 225 Compliance Overview

Blunt Business speaks with Jonathan Wachs regarding the DEA’s proposed Schedule 3 rescheduling process, the launching of the Form 225 registration portal for medical cannabis operators, and the regulatory and compliance challenges facing businesses in dual-use markets.

The Drug Enforcement Administration (DEA) has launched its Schedule 3 registration portal using Form 225 for medical cannabis manufacturers, distributors, and analytical laboratories. Applying through the system involves substantial non-refundable annual registration fees, set at $3,699 for manufacturers, $1,850 for distributors, and $296 for analytical labs.

Given the complexity of the disclosures required on Form 225, Wachs advises operators to retain legal counsel to ensure accurate filings and navigate potential legal exposures.

Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy